github link
Accession IconGSE47994

Tumor infiltrating lymphocytes, prognosis and trastuzumab benefit in early-stage breast cancer

Organism Icon Homo sapiens
Sample Icon 335 Downloadable Samples
Technology Badge Icon Affymetrix Human Genome U219 Array (hgu219)

Submitter Supplied Information

Description
The clinical relevance of tumor infiltrating lymphocytes (TILs) in breast cancer (BC) is not firmly established. We aimed to validate previous prognostic findings in triple negative breast cancer (TNBC) and investigate predictive associations with trastuzumab benefit in HER2 overexpressing disease (HER2+).
PubMed ID
No associated PubMed ID
Publication Title
No associated publication
Total Samples
335
Submitter’s Institution
Authors
No associated authors
Source Repository
Alternate Accession IDs

Samples

Show
of 0 Total Samples
Filter
Add/Remove
Accession Code
Title
Specimen part
Disease stage
Processing Information
Additional Metadata
No rows found
Loading...
Some fields may be harmonized. Learn more